Dongwha Pharm.Co.Ltd (000020) — Cash Flow Quality Index
Dongwha Pharm.Co.Ltd (000020) has a Cash Flow Quality Index of 0.07x as of March 2026. Operating cash flow of ₩697.02 Million is below net income of ₩10.02 Billion, suggesting accrual-heavy earnings not yet converted to cash. Explore Dongwha Pharm.Co.Ltd debt service capacity to assess how comfortably operating cash covers total debt obligations.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Dongwha Pharm.Co.Ltd Cash Flow Quality Index (2011–2025)
Historical Cash Flow Quality Index for Dongwha Pharm.Co.Ltd across 15 annual periods. Values consistently above 1.0x indicate high-quality earnings. For the full cash flow conversion analysis, see 000020 cash flow metrics.
Annual Cash Flow Quality Index for Dongwha Pharm.Co.Ltd (2011–2025)
Year-by-year earnings quality comparison for Dongwha Pharm.Co.Ltd.
| Year | Quality Index | Operating CF (KRW) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 1.81x | ₩15.70 Billion | ₩8.69 Billion | ▲ +351.2% |
| 2024 | -0.72x | ₩-4.00 Billion | ₩5.56 Billion | ▼ -167.7% |
| 2023 | 1.06x | ₩29.17 Billion | ₩27.44 Billion | ▼ -25.8% |
| 2022 | 1.43x | ₩29.22 Billion | ₩20.38 Billion | ▼ -28.9% |
| 2021 | 2.02x | ₩36.03 Billion | ₩17.87 Billion | ▲ +10.1% |
| 2020 | 1.83x | ₩52.23 Billion | ₩28.51 Billion | ▲ +29.7% |
| 2019 | 1.41x | ₩13.28 Billion | ₩9.40 Billion | ▲ +426.3% |
| 2018 | -0.43x | ₩-4.36 Billion | ₩10.07 Billion | ▼ -23.2% |
| 2017 | -0.35x | ₩-16.52 Billion | ₩47.01 Billion | ▼ -136.2% |
| 2016 | 0.97x | ₩25.48 Billion | ₩26.25 Billion | ▼ -72.6% |
| 2015 | 3.54x | ₩19.83 Billion | ₩5.61 Billion | ▲ +29.2% |
| 2014 | 2.74x | ₩13.51 Billion | ₩4.94 Billion | ▼ -66.2% |
| 2013 | 8.11x | ₩8.21 Billion | ₩1.01 Billion | ▼ -57.9% |
| 2012 | 19.24x | ₩25.23 Billion | ₩1.31 Billion | ▲ +635.5% |
| 2011 | 2.62x | ₩46.24 Billion | ₩17.68 Billion | — |